Follow-up Repeat broad markers after 6-12 weeks if the protocol continues, symptoms change, or there are concerns about inflammation, infection, bruising, swelling, or recovery quality
Molecular mechanisms and therapeutic target of netosis in diseases
Mitochondrial diseases
Consistent Quality Standards Rigorous QC protocols ensure batch-to-batch consistency for reliable research outcomes
doi:10.3390/nu4101399, PMID: 23201762 Peltoniemi M, Kaarteenaho-Wiik R, Sily M, Sormunen R, Pkk P, Holmgren A, Soini Y, Kinnula VL (2004) Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo